How Much Does PT-141 (bremelanotide) Cost in 2026? Pricing Breakdown

Key Takeaways

• PT-141 (bremelanotide) is not FDA-approved and is available only for research purposes, affecting its cost and availability.
• Typical costs for PT-141, where available, range from $300 to $500 per dose, with compounded versions potentially lower.
• Insurance coverage for PT-141 is unlikely due to its research-only status, meaning most patients pay out of pocket.
• Utilizing HSA/FSA funds for PT-141 may be possible, but it depends on specific plan allowances and legal status.
• Telehealth services might offer bundled pricing, including consultation and medication, which could be more cost-effective.

What Is PT-141 (bremelanotide)?

PT-141, also known as bremelanotide, is a synthetic peptide classified as a melanocortin receptor agonist. It primarily targets the MC4R receptor, influencing central nervous system pathways. Currently, PT-141 is available for research purposes only and is not FDA-approved for therapeutic use. For more information, visit the full profile.

Typical Cost Ranges

As PT-141 is not FDA-approved and is available solely for research, its cost is not standardized. However, anecdotal data suggest that costs range from $300 to $500 per dose in markets where it is accessible. Compounded versions, if legally available, might offer a reduced price, potentially ranging from $200 to $400 per dose. Monthly costs depend on dosing frequency, which varies by research protocol.

Insurance Coverage

Due to its research-only status, PT-141 is typically not covered by insurance. FDA-approved medications are more likely to receive coverage, whereas compounded and research peptides like PT-141 rarely qualify. Patients interested in exploring insurance options should consult their provider about specific policy details, including prior authorization and step therapy requirements.

HSA/FSA Eligibility

The eligibility of PT-141 for HSA/FSA spending depends on the specific plan and legal status of the peptide. Generally, treatments that are not FDA-approved may not qualify, but exceptions can occur based on individual plan allowances. Patients should verify eligibility with their plan administrator.

Telehealth vs. In-Person Pricing

Telehealth clinics often provide cost-effective options by bundling consultations and medications into monthly programs. These packages may range from $500 to $800 per month, depending on the frequency of use and additional services offered. In-person clinics might charge separately for consultations and medications, leading to higher overall costs.

Ways to Reduce Cost

Patients can explore several strategies to mitigate the cost of PT-141:

• Manufacturer Savings Programs: While not common for research peptides, checking with suppliers for any available discounts may be beneficial.
• Compounding Pharmacies: If legal, these pharmacies might offer more affordable versions of PT-141.
• Patient Assistance Programs: These programs are typically for FDA-approved medications but checking for any available options could be worthwhile.
• Discount Tools: Platforms like GoodRx may offer savings on peptide purchases, although availability varies.

Cost Compared to Alternatives

When comparing PT-141 to similar peptides or alternative treatments, it's important to consider both cost and efficacy. For instance, Melanotan II, another melanocortin receptor agonist, might offer similar effects but with different cost structures. Melanotan II typically costs between $150 and $300 per dose, depending on the supplier and formulation.

What to Ask Your Provider About Cost

Patients should consider asking their healthcare provider the following questions regarding PT-141 costs:

• What are the total expected costs for PT-141 therapy, including consultations and follow-ups?
• Are there any cost-saving programs or discounts available for this peptide?
• How does the cost of PT-141 compare to other treatment options you might recommend?
• Can any part of the therapy be covered by insurance, HSA, or FSA?

FAQ

Is PT-141 (bremelanotide) covered by insurance?

Due to its research-only status, PT-141 is generally not covered by insurance. Most patients pay out of pocket.

Can I use my HSA/FSA to pay for PT-141?

Eligibility for HSA/FSA spending depends on your specific plan and the legal status of the peptide. Verify with your plan administrator.

How much does PT-141 cost per month?

Monthly costs vary but typically range from $500 to $800, depending on dosing frequency and whether services are bundled.

Are there any discounts available for PT-141?

While manufacturer savings programs are rare, checking with suppliers for discounts or using platforms like GoodRx might help reduce costs.

How does PT-141 compare to Melanotan II in terms of cost?

Melanotan II usually costs between $150 and $300 per dose, making it potentially less expensive than PT-141, depending on the supplier.

---

This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any treatment.